FICARRA, Paola
 Distribuzione geografica
Continente #
NA - Nord America 4.643
EU - Europa 3.151
AS - Asia 2.136
SA - Sud America 901
AF - Africa 76
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.918
Nazione #
US - Stati Uniti d'America 4.587
IE - Irlanda 841
BR - Brasile 818
SG - Singapore 809
SE - Svezia 712
CN - Cina 711
UA - Ucraina 477
DE - Germania 374
HK - Hong Kong 345
GB - Regno Unito 211
FI - Finlandia 204
IT - Italia 104
IN - India 66
RU - Federazione Russa 51
FR - Francia 49
CA - Canada 34
PL - Polonia 31
TR - Turchia 31
VN - Vietnam 31
AR - Argentina 25
IQ - Iraq 22
IR - Iran 22
MA - Marocco 22
ZA - Sudafrica 21
BD - Bangladesh 19
EC - Ecuador 18
ES - Italia 16
MX - Messico 16
AT - Austria 13
BE - Belgio 12
JP - Giappone 12
CI - Costa d'Avorio 11
PK - Pakistan 11
CZ - Repubblica Ceca 10
NL - Olanda 10
TN - Tunisia 9
CO - Colombia 8
UZ - Uzbekistan 8
VE - Venezuela 8
ID - Indonesia 7
AZ - Azerbaigian 6
KE - Kenya 6
LV - Lettonia 6
OM - Oman 6
PE - Perù 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CL - Cile 5
PY - Paraguay 5
AL - Albania 4
IL - Israele 4
RS - Serbia 4
LT - Lituania 3
PH - Filippine 3
RO - Romania 3
AM - Armenia 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
JM - Giamaica 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
SA - Arabia Saudita 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.918
Città #
Jacksonville 892
Dublin 840
Chandler 530
Nyköping 429
Ashburn 392
Dallas 378
Hong Kong 344
Singapore 308
Beijing 279
Dearborn 190
Cambridge 139
Princeton 139
Medford 132
Des Moines 112
Los Angeles 95
Boardman 93
Lancaster 78
The Dalles 77
Buffalo 67
São Paulo 63
Ann Arbor 59
Jinan 59
Munich 54
Woodbridge 50
New York 39
Turku 38
Wilmington 38
Shenyang 35
Tianjin 33
Redondo Beach 30
San Mateo 26
Augusta 25
Belo Horizonte 24
Rio de Janeiro 24
Warsaw 24
Helsinki 23
Nanjing 23
Brasília 22
Hangzhou 22
Pune 22
Houston 21
Montreal 20
Nanchang 19
Ardabil 18
Brooklyn 18
Haikou 18
Leawood 18
Bremen 17
Campinas 15
Zhengzhou 15
Atlanta 14
Hebei 14
Ho Chi Minh City 14
Phoenix 14
Guangzhou 13
Vienna 13
Brussels 12
Frankfurt am Main 12
Abidjan 11
Chennai 11
Denver 11
Ningbo 11
Porto Alegre 11
Taizhou 11
Tokyo 11
Goiânia 10
Johannesburg 10
Manaus 10
Messina 10
Seattle 10
Auburn Hills 9
Boston 9
Fortaleza 9
Fuzhou 9
London 9
Poplar 9
San Francisco 9
Santa Clara 9
Brno 8
Guayaquil 8
Mumbai 8
Stockholm 8
Tashkent 8
Washington 8
Baghdad 7
Casablanca 7
Curitiba 7
Elk Grove Village 7
Hyderabad 7
Saint Petersburg 7
Seropédica 7
Aracaju 6
Baku 6
Chicago 6
Guarulhos 6
Hefei 6
Jiaxing 6
Mexico City 6
Monmouth Junction 6
Montevideo 6
Totale 6.882
Nome #
Anticonvulsant agent: enhancement of physicochemical properties 130
AMPHIPHILIC CYCLODEXTRINS AS NANOCARRIERS OF GENISTEIN: A SPECTROSCOPIC INVESTIGATION POINTING OUT THE STRUCTURAL PROPERTIES OF THE HOST/ ISOFLAVONE COMPLEX SYSTEM IN WATER AND AT THE SOLID STATE 125
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 117
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 116
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 116
SEPARAZIONE E DETERMINAZIONE MEDIANTE HPLC IN FASE INVERSA DI DERIVATI DEL 2-FENILCROMONE E DELL'ACIDO CLOROGENICO DA ESTRATTI DI CRATAEGUS OXYACANTHA L. 114
BETA-BLOCKERS CHARACTERIZATION BY UV-VIS ABSORPTION AND REFLECTIVITY IN DIFFERENT CHEMICAL ENVIRONMENTS 112
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 110
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 110
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 110
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 109
Analytical profile and release of lonidamine from pharmaceutical formulation 109
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 107
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 104
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 104
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 103
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 103
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES. 103
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 101
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 101
Amphiphilic Cyclodextrins as Nanocarriers of Genistein: aSpectroscopic Investigation Pointing out the StructuralProperties of the Host/Drug Complex System 101
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 99
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 99
Cromatografia liquida ad alta efficienza nell'analisi farmaceutica: separazione e determinazione di una miscela diuretica-antipertensiva 98
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 98
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 98
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 97
PHYSICO-CHEMICAL CHARACTERIZATION OF AN AMPHIPHILIC CYCLODEXTRIN/GENISTEIN COMPLEX 97
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 96
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 95
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 94
MISURE DI LIPOFILICITA' DI FLAVONI MEDIANTE CROMATOGRAFIA LIQUIDA IN FASE INVERSA 92
ANALISI DI FLUNARIZINA BICLORIDRATO IN FORME FARMACEUTICHE MEDIANTE CROMATOGRAFIA LIQUIDA AD ALTA PRESSIONE 92
A CHEMOMETRIC APPROACH FOR THE SEPARATION OF SOME PSYCHOTROPIC DRUGS AND THEIR METABOLITES BY LIQUID CHROMATOGRAPHY 92
Variable-ionic strength kinetic experiments in drug stability studies 92
Phisicochemical characterization of cumestrol beta-cyclodextrins inclusion complexes by UV-Vis anf FTIR-ATR spectyroscopies 92
INCAPSULATION OF LUTEIN IN AMPHIPHILIC -CYCLODEXTRIN NANOPARTICLES FOR THE APPLICATION IN DRUG DELIVERY. 92
Gemcitabine-Loaded Chitosan Microspheres For Local Delivery In Lung, 92
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 89
Determination of fludarabine in a pharmaceutical formulation by LC 89
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 89
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. SEPARATION AND IDENTIFICATION OF FLAVONOIDS IN CRATAEGUS OXYACANTHA L. Note IV. Apigenin, Apigenin-7-glucoside, Luteolin, Luteolin-3',7-diglucoside 88
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 88
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 88
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 88
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 87
Physicochemical characterization of coumestrol/beta-cyclodextrins inclusion complexes by UV-vis and FTIR-ATR spectroscopies 87
Cromatografia liquida nell'analisi farmaceutica: determinazione nelle compresse della famotidina, nuovo H2-antagonista 86
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 86
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 86
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 85
Determinazione del trans-1-bis(4-fluorofenil)metil-4-(3-fenil-2-propenil)piperazina dicloridrato mediante HPLC 84
Dosaggio mediante HPLC di atenololo e clortalidone associati in forme farmaceutiche 84
NANOAGGREGATES OF AMPHIPHILIC CYCLODEXTRIN WITH GENISTEIN: A SPECTROSCOPY CHARACTERISATION BY UV-VIS, DYNAMIC LIGHT SCATTERING AND FTIR-ATR 84
METAL-COMPLEXES OF BENZODIAZEPINES . PART 2. THE REACTION OF 1,4- BENZODIAZEPINES WITH HALIDE-BRIDGED COMPLEXES OF PALLADIUM(II) [PD2X4(PPRN3)2] (X = CL OR I) 83
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 82
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 81
GEMCITABINE-LOADED CHITOSAN MICROSPHERES FOR LOCAL DELIVERY IN LUNG 81
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND DIFFUSE REFLECTANCE SPECTROSCOPY OF FLAVONOIDS IN CRATEGUS-OXYACANTHA L .3. ANALYSIS OF 2-PHENYL-CHROMAN DERIVATIVES AND CAFFEIC ACID 80
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 79
CROMATOGRAFIA LIQUIDA AD ALTA RISOLUZIONE NELL'ANALISI DI PREPARAZIONI ESTRATTIVE DI FOGLIE E GERMOGLI DI OLEA EUROPAEA L. 78
Validation of variable-parameter kinetic methods for accelerated studies on drug stability 78
CROMATOGRAFIA LIQUIDA NELL'ANALISI FARMACEUTICA: SEPARAZIONE E DETERMINAZIONE DI FAMOTIDINA, NUOVO H2-ANTAGONISTA 77
PROFILI TEMPERATURA-VELOCITA' DA CINETICHE POLARIMETRICHE A TEMPERATURA VARIABILE 77
Nuclear magnetic resonance of psychotherapeutic agents. IV. Conformational analysis of 2,3-dihydro.1H-1,4-benzodiazepines 77
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 76
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 76
IMPROVEMENT OF FLAVONOIDS DISSOLUTION PROPERTIES BY COMPLEXATION WITH BETA-CYCLODEXTRIN 76
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 75
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 75
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 74
VALIDATION OF A LIQUID CROMATOGRAPHIC METHOD FOR THE ANALYSIS OF ZAFIRLUKAST IN A PHARMACEUTICAL FORMULATION 73
FTIR-ATR spectroscopy to probe selective protein recognition by cyclodextrin nanoaggregates 73
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 72
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 72
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 72
MODELLO DI INTERAZIONE SELECTORS-SELCTANDS NEL PROCESSO DI DISCRIMINAZIONE CHIRALE. 72
Nuclear magnetic resonance of 1,4-benzodiazepines. II. Stereochemistry of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones by lanthanide shift reagents 72
Risonanza magnetica nucleare di 1,4-benzodiazepine. Accoppiamento attraverso lo spazio di 2,3-diidro-1H-1,4-benzodiazepine 1-sostituite 72
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 71
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 71
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 71
MODIFIED CYCLODEXTRINS IN THE SOLUBILIZATION OF SOME PHYTOESTROGENS 70
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF FLAVONOIDS IN CRATAEGUS-OXYACANTHA L .4. REVERSED-PHASE HIGH-PRESSURE LIQUID- CHROMATOGRAPHY IN FLOWER, LEAF AND BUD EXTRACTIVES OF CRATAEGUS-OXYACANTHA L 70
Study of the inclusion complex of atenolol with beta- cyclodextrins 70
STUDIO COMPARATIVO DI RISOLUZIONE ENANTIOMERICA DI NUOVI DERIVATI 2,3-BENZODIAZEPINICI AD ATTIVITA' ANTICONVULSIVANTE SU FASI STAZIONARIE CHIRALI DI NATURA POLISACCARIDICA. 70
Temperature-rate profiles by polarimetric variable-temperature kinetic experiments to study racemization reactions 69
Isolation and characterization of Guiera senegalensis J.F.Gmel. active principles. 69
ISOFLAVONES AND CYCLODEXTRINS: EVIDENCES OF COMPLEXATION BY COMPLEMENTARY SPECTROSCOPIC TECHNIQUES 69
Nuclear magnetic resonance spectra of psychotherapeutic agents. V. Conformational analysis of 1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-ones 69
FTIR-ATR SPECTROSCOPY TO PROBE SELECTIVE PROTEIN RECOGNITION BY CYCLODEXTRIN NANOAGGREGATES 68
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 68
OTTIMIZZAZIONE DI UN METODO ELETTROFORETICO PER L'ANALISI DI ISOFLAVONI E COUMESTANI 68
Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation 68
USE OF DIFFERENT CYCLODEXTRINS AS SOLUBILIZING AGENTS 67
STRUCTURE OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEX BY NMR, X-RAY AND DSC INVESTIGATION 67
SPECTROSCOPIC STUDIES ON THE QUERCETIN/(2-HYDROXYPROPYL)-B-CYCLODEXTRIN INTERACTIONS 67
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 67
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES 67
SIMULTANEOUS DETERMINATION OF METAPROLOL AND HYDROCLOROTHIAZIDE IN TWO COMPONENT TABLET FORMULATIONS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 66
Totale 8.653
Categoria #
all - tutte 41.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021512 0 0 0 0 7 133 6 130 1 82 125 28
2021/2022966 5 210 10 14 21 2 66 40 4 118 177 299
2022/20232.415 175 179 123 155 216 235 38 137 1.032 10 92 23
2023/2024411 65 75 34 50 39 81 6 14 0 16 2 29
2024/20252.313 36 36 38 157 88 40 39 517 585 126 217 434
2025/20261.856 347 406 475 493 135 0 0 0 0 0 0 0
Totale 10.959